BG107988A - Стабилизирани препарати за локално третиране с бривудин - Google Patents

Стабилизирани препарати за локално третиране с бривудин Download PDF

Info

Publication number
BG107988A
BG107988A BG107988A BG10798803A BG107988A BG 107988 A BG107988 A BG 107988A BG 107988 A BG107988 A BG 107988A BG 10798803 A BG10798803 A BG 10798803A BG 107988 A BG107988 A BG 107988A
Authority
BG
Bulgaria
Prior art keywords
iron oxide
brivudine
titanium dioxide
oxide
pharmaceutical composition
Prior art date
Application number
BG107988A
Other languages
Bulgarian (bg)
English (en)
Inventor
Ulrike Gehlert
Karsten Groger
Reinhard Schmitz
Karl-Heinz Schraeder
Andreas Schraeder
Marc Wihsmann
Carlo A. Maggi
Stefano Manzini
Bettina Stubinski
Original Assignee
Berlin-Chemie Ag
Menarini Ricerche S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berlin-Chemie Ag, Menarini Ricerche S.P.A. filed Critical Berlin-Chemie Ag
Publication of BG107988A publication Critical patent/BG107988A/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG107988A 2001-01-17 2003-07-10 Стабилизирани препарати за локално третиране с бривудин BG107988A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01100968 2001-01-17
PCT/EP2002/000163 WO2002056913A2 (fr) 2001-01-17 2002-01-10 Preparations topiques de brivudine stabilisees

Publications (1)

Publication Number Publication Date
BG107988A true BG107988A (bg) 2004-09-30

Family

ID=8176229

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107988A BG107988A (bg) 2001-01-17 2003-07-10 Стабилизирани препарати за локално третиране с бривудин

Country Status (28)

Country Link
US (1) US20040087602A1 (fr)
EP (1) EP1365772A2 (fr)
JP (1) JP2004519460A (fr)
KR (1) KR20030070109A (fr)
CN (1) CN1236777C (fr)
AR (1) AR035530A1 (fr)
AU (1) AU2002244642B2 (fr)
BG (1) BG107988A (fr)
BR (1) BR0206478A (fr)
CA (1) CA2434743A1 (fr)
CZ (1) CZ20031912A3 (fr)
EE (1) EE200300322A (fr)
HR (1) HRP20030559A2 (fr)
HU (1) HUP0302741A3 (fr)
IL (1) IL156933A0 (fr)
MA (1) MA26266A1 (fr)
MX (1) MXPA03006307A (fr)
MY (1) MY136633A (fr)
NO (1) NO20033206L (fr)
PE (1) PE20020818A1 (fr)
PL (1) PL365741A1 (fr)
RU (1) RU2280453C2 (fr)
SK (1) SK8992003A3 (fr)
TN (1) TNSN03036A1 (fr)
UA (1) UA80673C2 (fr)
WO (1) WO2002056913A2 (fr)
YU (1) YU57103A (fr)
ZA (1) ZA200305437B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005046769A1 (de) * 2005-09-29 2007-04-05 Berlin-Chemie Ag Lichtstabile, brivudinhaltige pharmazeutische Formulierung zur Behandlung von Augenherpes (Herpes Ophthalmicus)
FR2936706B1 (fr) * 2008-10-08 2010-12-17 Oreal Composition cosmetique contenant un derive de dibenzoylmethane et un compose dithiolane ; procede de photostabilisation du derive de dibenzoylmethane
JP5591128B2 (ja) * 2009-01-29 2014-09-17 大日本住友製薬株式会社 内核を有する口腔内崩壊錠
EP3272346A4 (fr) * 2015-03-19 2018-08-01 Daiichi Sankyo Company, Limited Colorant contenant une préparation solide
CN104988791A (zh) * 2015-06-25 2015-10-21 广东义晟实业有限公司 一种抗病毒添加剂及添加该添加剂的胶水和uv漆

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0072137A1 (fr) * 1981-08-01 1983-02-16 Beecham Group Plc Déoxyuridines à activité antivirale
HU196038B (en) * 1987-08-07 1988-09-28 Mta Koezponti Kemiai Kutato In Process for producing antiherpetic pharmaceutics for external use, containing 5-isopropyl-2'-beta-deoxy-uridine
DE4122337A1 (de) * 1991-07-05 1993-01-14 Cedona Pharm Bv Pharmazeutische zubereitung
FR2737118B1 (fr) * 1995-07-28 1997-09-05 Oreal Composition dermatologique ou pharmaceutique, procede de preparation et utilisation
GB9521454D0 (en) * 1995-10-19 1995-12-20 Kappa Pharmaceuticals Ltd Compositions for the treatment of conditions caused by herpes virus
US6558710B1 (en) * 1999-06-14 2003-05-06 Helen Rebecca Godfrey Topical zinc compositions and methods of use
DE10162593A1 (de) * 2001-12-19 2003-07-03 Menarini Ricerche Spa Stabilisierte topische Brivudin-Formulierungen

Also Published As

Publication number Publication date
PL365741A1 (en) 2005-01-10
NO20033206D0 (no) 2003-07-15
UA80673C2 (en) 2007-10-25
CN1236777C (zh) 2006-01-18
TNSN03036A1 (en) 2005-04-08
MY136633A (en) 2008-11-28
KR20030070109A (ko) 2003-08-27
CN1486185A (zh) 2004-03-31
AU2002244642B2 (en) 2005-12-15
HRP20030559A2 (en) 2005-06-30
YU57103A (sh) 2006-08-17
MA26266A1 (fr) 2004-09-01
WO2002056913A3 (fr) 2002-11-07
CZ20031912A3 (cs) 2004-01-14
PE20020818A1 (es) 2002-10-21
CA2434743A1 (fr) 2002-07-25
SK8992003A3 (en) 2003-11-04
US20040087602A1 (en) 2004-05-06
BR0206478A (pt) 2003-12-30
HUP0302741A3 (en) 2007-06-28
JP2004519460A (ja) 2004-07-02
EE200300322A (et) 2003-10-15
RU2280453C2 (ru) 2006-07-27
WO2002056913A2 (fr) 2002-07-25
IL156933A0 (en) 2004-02-08
HUP0302741A2 (hu) 2003-11-28
ZA200305437B (en) 2004-07-15
EP1365772A2 (fr) 2003-12-03
NO20033206L (no) 2003-07-15
MXPA03006307A (es) 2003-09-16
RU2003121639A (ru) 2005-02-10
AR035530A1 (es) 2004-06-02

Similar Documents

Publication Publication Date Title
KR100309399B1 (ko) 피부외용제
US4963555A (en) Formulations of heterocyclic compounds
JPH09506865A (ja) 新規組成物
CA1172169A (fr) Composes heterocycliques
KR20010101715A (ko) 외용 조성물
ITMI970408A1 (it) Sistemi gelificati di nimesulide per uso topico
DE69411090T2 (de) Kosmetisches Präparat mit einer Zusammensetzung einer Superoxyd Dismutase und eines Melaninpigmentes
CA2470629A1 (fr) Preparations topiques stabilisees de brivudine
BG107988A (bg) Стабилизирани препарати за локално третиране с бривудин
WO1997034607A1 (fr) Formulations d'aciclovir a usage local
JP4591746B2 (ja) 難溶性抗ウイルス成分含有水溶性外用剤組成物
AU2002244642A1 (en) Stabilized brivudine topical formulations containing metal oxide pigments
NZ205587A (en) Composition comprising undecylenic acid for treating herpes simplex i
JP2010030933A (ja) 皮膚外用剤
AU768989B2 (en) Aciclovir compositions containing dimethicone
CA2351463C (fr) Formulations antivirales renfermant du propylene glycol et un ester acide alkanoique d'isopropyle
JP2000178118A (ja) 保湿剤及び皮膚化粧料並びに入浴剤
WO2023017733A1 (fr) Stabilisation de l'acide aminé de type mycosporine
HU196038B (en) Process for producing antiherpetic pharmaceutics for external use, containing 5-isopropyl-2'-beta-deoxy-uridine
JPH034044B2 (fr)
KR20120103768A (ko) ｐＨ 조절을 통해 안정화된 프룩토오스 1,6-디포스페이트 화합물을 함유하는 피부 외용제 조성물
JPH05124947A (ja) メラニン生成抑制外用剤
WO1997045123A1 (fr) Formulations pharmaceutiques topiques comprenant de l'aciclovir
JPH11501625A (ja) ヒト・ヘルペスウイルス−８の治療に対するペンシクロビルの使用
JPH05124948A (ja) メラニン生成抑制外用剤